Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

INTRODUCTION: In previous studies, we successfully designed complex multicompartmental microcapsules as a platform for the oral targeted delivery of lipophilic drugs in type 2 diabetes (T2D). Probucol (PB) is an antihyperlipidemic and antioxidant drug with the potential to show benefits in T2D. We a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Al-Sallami, Hesham S, Fang, Zhongxiang, Mukkur, TK, Mikov, Momir, Golocorbin-Kon, Svetlana, Fakhoury, Marc, Watts, Gerald F, Matthews, Vance, Arfuso, Frank, Al-Salami, Hani
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4166910/
https://ncbi.nlm.nih.gov/pubmed/25246766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S67349
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares